Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients.
Proteomic analysis of the anti-inflammatory action of minocycline.
What to expect after natalizumab cessation in a real-life setting.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Natalizumab treatment reduces endothelial activity in MS patients.
Inpatient Rehabilitation Utilization for Medicare Beneficiaries with Multiple Sclerosis.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
Multiple sclerosis: a comprehensive review for the physician assistant.
Low-Voltage-Activated CaV3.1 Calcium Channels Shape T Helper Cell Cytokine Profiles.
Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
Structural mechanism for statin inhibition of HMG-CoA reductase.
Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
Stem cell therapy for white matter disorders: don't forget the microenvironment!
Multiple sclerosis: basic knowledge and new insights in perioperative management.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Polyunsaturated fatty acids in multiple sclerosis therapy.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
Comorbid Multiple Sclerosis and TDP-43 Proteinopathy in a Gulf War Sea Captain.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.

Pages